Nifty
Sensex
:
:
11896.80
40544.37
23.75 (0.20%)
112.77 (0.28%)

Pharmaceuticals & Drugs - API

Rating :
67/99  (View)

BSE: 506235 | NSE: ALEMBICLTD

97.85
1.90 (1.98%)
20-Oct-2020 | 3:58PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  96.30
  •  98.90
  •  96.05
  •  95.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  409451
  •  400.65
  •  122.80
  •  24.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,465.11
  • 6.47
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,406.25
  • 0.63%
  • 1.74

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.41%
  • 0.72%
  • 20.72%
  • FII
  • DII
  • Others
  • 1.84%
  • 3.90%
  • 2.41%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -9.59
  • -10.33
  • -16.13

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.78
  • -12.15
  • -22.29

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 30.35
  • 30.58

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.38
  • 6.46
  • 6.59

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.36
  • 1.32
  • 1.20

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.81
  • 28.30
  • 26.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
13
26
-49%
11
25
-55%
13
24
-48%
24
34
-30%
Expenses
13
25
-49%
12
22
-45%
13
21
-39%
21
27
-23%
EBITDA
1
1
-47%
-1
3
-
0
3
-
3
6
-58%
EBIDTM
6%
5%
14%
13%
-1%
13%
11%
19%
Other Income
3
1
91%
57
2
2348%
2
2
30%
33
24
35%
Interest
0
0
29%
0
0
50%
0
0
40%
0
0
50%
Depreciation
1
1
35%
1
1
27%
1
1
31%
1
1
27%
PBT
3
2
19%
56
5
1033%
1
4
-76%
34
30
15%
Tax
0
1
-33%
0
1
-83%
0
1
-99%
-1
1
-
PAT
2
1
42%
55
4
1294%
1
3
-71%
35
29
20%
PATM
16%
6%
7%
16%
7%
13%
149%
87%
EPS
0.08
0.06
33%
2.16
0.15
1340%
0.04
0.13
-69%
1.37
1.14
20%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Net Sales
61
74
124
125
147
128
144
1,138
1,116
994
Net Sales Growth
-44%
-40%
-1%
-15%
15%
-11%
-87%
2%
12%
 
Cost Of Goods Sold
4,663
12
67
78
96
70
74
572
559
484
Gross Profit
-4,601
62
57
47
51
58
70
566
557
510
GP Margin
-7,509%
84%
46%
37%
35%
45%
49%
50%
50%
51%
Total Expenditure
59
71
106
114
140
122
135
1,025
1,032
848
Power & Fuel Cost
-
1
2
1
5
13
13
34
38
28
% Of Sales
-
1%
2%
1%
4%
10%
9%
3%
3%
3%
Employee Cost
-
21
21
20
23
24
27
145
132
98
% Of Sales
-
28%
17%
16%
16%
19%
19%
13%
12%
10%
Manufacturing Exp.
-
26
7
6
7
6
12
92
96
91
% Of Sales
-
35%
6%
5%
5%
5%
8%
8%
9%
9%
General & Admin Exp.
-
8
7
7
6
5
5
77
68
53
% Of Sales
-
11%
6%
5%
4%
4%
3%
7%
6%
5%
Selling & Distn. Exp.
-
1
0
0
1
2
3
92
87
80
% Of Sales
-
1%
0%
0%
1%
2%
2%
8%
8%
8%
Miscellaneous Exp.
-
2
2
2
1
2
2
12
51
15
% Of Sales
-
3%
2%
1%
1%
1%
1%
1%
5%
1%
EBITDA
3
3
17
11
7
6
9
114
84
146
EBITDA Margin
4%
4%
14%
9%
5%
5%
6%
10%
8%
15%
Other Income
95
94
30
37
31
29
22
11
15
35
Interest
0
0
0
0
0
0
1
38
52
35
Depreciation
3
3
3
4
5
6
6
43
38
33
PBT
94
93
45
44
32
29
23
44
9
114
Tax
0
0
4
2
-1
1
-1
4
-2
2
Tax Rate
0%
0%
8%
5%
-3%
2%
-3%
10%
-19%
2%
PAT
94
93
41
42
27
25
24
40
11
112
PAT before Minority Interest
94
93
41
42
27
25
24
40
11
112
Minority Interest
0
0
0
0
0
0
0
0
0
0
PAT Margin
153%
126%
33%
33%
19%
19%
17%
3%
1%
11%
PAT Growth
146%
126%
-2%
52%
11%
2%
-39%
265%
-90%
 
EPS
3.65
3.62
1.60
1.63
1.07
0.96
0.94
1.54
0.42
4.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Shareholder's Funds
1,418
1,209
1,086
911
803
528
337
331
341
Share Capital
51
51
53
53
53
53
27
27
28
Total Reserves
1,367
1,157
1,032
858
750
474
311
304
314
Non-Current Liabilities
7
9
14
13
15
38
422
482
419
Secured Loans
0
0
0
0
0
0
249
216
278
Unsecured Loans
0
0
0
0
0
0
159
260
146
Long Term Provisions
1
1
1
1
1
2
0
0
0
Current Liabilities
46
49
59
68
58
82
270
230
204
Trade Payables
13
25
16
15
16
19
198
169
137
Other Current Liabilities
22
8
32
39
27
26
20
19
15
Short Term Borrowings
0
0
0
0
0
0
0
0
0
Short Term Provisions
11
16
11
14
14
36
52
42
52
Total Liabilities
1,471
1,266
1,159
992
876
648
1,029
1,043
964
Net Block
131
187
147
148
146
169
393
405
367
Gross Block
145
202
160
158
372
402
712
682
606
Accumulated Depreciation
15
16
13
11
225
233
319
277
239
Non Current Assets
1,308
1,167
972
801
706
458
405
420
401
Capital Work in Progress
3
22
32
0
0
2
4
7
22
Non Current Investment
1,173
958
793
651
559
287
8
8
13
Long Term Loans & Adv.
1
0
0
2
1
0
0
0
0
Other Non Current Assets
0
0
0
0
0
0
0
0
0
Current Assets
163
99
187
191
169
189
624
623
563
Current Investments
54
43
120
105
46
12
0
0
1
Inventories
35
35
32
51
75
84
245
238
203
Sundry Debtors
9
14
25
22
28
48
193
213
231
Cash & Bank
59
2
1
2
2
3
24
16
19
Other Current Assets
6
2
2
2
18
42
162
155
109
Short Term Loans & Adv.
4
3
6
10
16
42
162
155
109
Net Current Assets
117
50
128
123
112
108
354
393
359
Total Assets
1,471
1,266
1,159
992
876
648
1,029
1,043
964

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
6
22
24
52
10
149
123
54
PBT
93
45
44
27
25
44
17
91
Adjustment
-86
-21
-29
-21
-17
73
114
60
Changes in Working Capital
0
2
12
46
2
36
-4
-110
Cash after chg. in Working capital
8
26
27
52
11
153
126
41
Interest Paid
0
0
0
0
0
0
0
0
Tax Paid
-2
-5
-4
0
-1
-4
-3
-3
Other Direct Exp. Paid
0
0
0
0
0
0
0
-7
Extra & Other Items
0
0
0
0
0
0
0
0
Cash From Investing Activity
57
72
-22
-47
-5
-24
-56
-225
Net Fixed Assets
76
-33
-33
213
344
-27
-61
Net Investments
-86
71
-63
-62
-141
0
6
Others
67
34
75
-198
-208
4
0
Cash from Financing Activity
-6
-92
-3
-5
-5
-118
-70
39
Net Cash Inflow / Outflow
57
1
-1
0
0
7
-2
-133
Opening Cash & Equivalents
2
1
2
2
3
16
19
152
Closing Cash & Equivalent
59
2
1
2
2
24
16
19

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
55
47
41
34
30
20
13
12
12
ROA
7%
3%
4%
3%
3%
3%
4%
1%
12%
ROE
7%
4%
4%
3%
4%
6%
12%
3%
33%
ROCE
7%
4%
4%
3%
4%
4%
11%
8%
19%
Fixed Asset Turnover
0.43
0.69
0.80
0.58
0.35
0.27
1.65
1.76
1.70
Receivable days
56
56
67
59
103
294
64
71
82
Inventory Days
175
98
119
150
217
402
77
71
72
Payable days
120
75
56
40
61
332
69
57
60
Cash Conversion Cycle
110
80
131
168
259
364
73
86
94
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
1.21
1.44
1.24
Interest Cover
324
208
262
169
221
29
2
1
4

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.